Skip to content

13F-HR filed by Bayesian Capital Management, LP

Bayesian Capital Management, LP filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-14, with 502 holding rows worth $453,393,000.

Accession
0001420506-20-000955
Filed
2020-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2020

A holdings report, 502 entries on the cover page, a total value of $453,393,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $453,393,000 with VALUE read as thousands by filing date, 13F file number 028-17330. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GENESIS HEALTHCARE CLASS A37185X106COMMON STOCK12,832$9,000thousands by filing date
NOVUS THERAPEUTICS INC67011N105COM11,601$5,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-20-000955this filing2020-08-14acceptance time not in the bulk data set